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Abstract
Background: Heart rate variability (HRV), or variation in beat-to-beat intervals of the heart, is a quantitative measure of
autonomic regulation of the cardiovascular system. Low HRV derived from electrocardiogram (ECG) recordings is reported to
be related to physical frailty in older adults. Recent advances in wearable technology offer opportunities to more easily integrate
monitoring of HRV into regular clinical geriatric health assessments. However, signals obtained from ECG versus wearable
photoplethysmography (PPG) devices are different, and a critical first step preceding their widespread use is to determine whether
HRV metrics derived from PPG devices also relate to older adults’ physical function.
Objective: This study aimed to investigate associations between HRV measured with a wrist-worn PPG device, the Empatica
E4 sensor, and validated clinical measures of both objective and self-reported physical function in a cohort of older adults living
independently within a continuing care senior housing community. Our primary hypothesis was that lower HRV would be
associated with lower physical function. In addition, we expected that HRV would explain a significant proportion of variance
in measures of physical health status.
Methods: We evaluated 77 participants from an ongoing study of older adults aged between 65 and 95 years. The assessments
encompassed a thorough examination of domains typically included in a geriatric health evaluation. We collected HRV data with
the Empatica E4 device and examined bivariate correlations between HRV quantified with the triangular index (HRV TI) and 3
widely used and validated measures of physical functioning—the Short Physical Performance Battery (SPPB), Timed Up and
Go (TUG), and Medical Outcomes Study Short Form 36 (SF-36) physical composite scores. We further investigated the additional
predictive power of HRV TI on physical health status, as characterized by SF-36 physical composite scores and Cumulative
Illness Rating Scale for Geriatrics (CIRS-G) scores, using generalized estimating equation regression analyses with backward
elimination.
Results: We observed significant associations of HRV TI with SPPB (n=52; Spearman ρ=0.41; P=.003), TUG (n=51; ρ=−0.40;
P=.004), SF-36 physical composite scores (n=49; ρ=0.37; P=.009), and CIRS-G scores (n=52, ρ=−0.43; P=.001). In addition,
the HRV TI explained a significant proportion of variance in SF-36 physical composite scores (R2=0.28 vs 0.11 without HRV)
and CIRS-G scores (R2=0.33 vs 0.17 without HRV).
JMIR Mhealth Uhealth 2019 | vol. 7 | iss. 10 | e13757 | p. 1http://mhealth.jmir.org/2019/10/e13757/
(page number not for citation purposes)
Graham et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
Conclusions: The HRV TI measured with a relatively novel wrist-worn PPG device was related to both objective (SPPB and
TUG) and self-reported (SF-36 physical composite) measures of physical function. In addition, the HRV TI explained additional
variance in self-reported physical function and cumulative illness severity beyond traditionally measured aspects of physical
health. Future steps include longitudinal tracking of changes in both HRV and physical function, which will add important insights
regarding the predictive value of HRV as a biomarker of physical health in older adults.
(JMIR Mhealth Uhealth 2019;7(10):e13757)  doi: 10.2196/13757
KEYWORDS
wearable technology; aging; electrocardiogram; geriatric assessment
Introduction
Background
Heart rate variability (HRV), or variation in beat-to-beat
intervals of the heart, is a quantitative measure of autonomic
regulation of the cardiovascular system that reflects the ability
of the system to react to stressors [1-3]. Low HRV indicates
improper coordination between the sympathetic and
parasympathetic nervous systems and is a well-established
predictor of future cardiovascular disease [4-8]. HRV is also
linked to other aspects of health that are directly impacted by
autonomic function such as self-regulatory capacity and
psychological and physiological stress [5,9,10]. Most HRV
metrics are shown to decline normally with age, primarily during
younger decades, and some of these metrics increase again after
the seventh decade [4,11-15]. In studies of older adults, low
HRV measured by electrocardiogram (ECG) recordings has
shown preliminary relationships with physical frailty [16-19].
Thus, measurement of HRV may add important information to
an assessment of older adults’ physical functioning and help to
identify individuals at higher risk for physical decline.
Heart Rate Variability Measurement
HRV is traditionally measured in clinical or laboratory settings
using standard ECG equipment or in the field with a 24-hour
Holter monitor [20]. Although accurate, these measures are time
consuming, require expert setup, and are obtrusive, making
them less appropriate for health assessments and unlikely to be
routine. Recent advances in technology enable measurement of
HRV in more ecologically valid settings with unobtrusive
wearable devices [21,22]. For example, wrist-worn devices
capture HRV via photoplethysmography (PPG) sensors that
detect blood volume changes in the microvasculature with each
heartbeat [22-24]. These blood volume changes allow the
determination of a PPG-derived peak-to-peak (P-P) interval,
which is a valid proxy measure of the R-R interval derived from
ECG recordings [25-27]. P-P or R-R intervals are also known
as interbeat intervals and reflect the durations between
successive heartbeats. HRV can be calculated from interbeat
intervals with many different metrics (eg, time domain: standard
deviation of normal-to-normal index; geometric: triangular
index [TI]; and frequency domain: low frequency to high
frequency power ratio) [3,20,28]. Selecting the appropriate HRV
metric requires careful consideration of the length of recording
and quality of the data. Wrist-worn PPG devices for HRV
monitoring are increasing in popularity because of their ease of
use; however, there is very little literature regarding the clinical
use of these devices [29]. A critical step toward understanding
the utility of these devices is to determine if and how HRV
metrics derived from wrist-worn PPG devices relate to the
physical function of older adults. To our knowledge, this is the
first study using a wrist-worn PPG device to derive HRV in an
older adult population.
Study Purpose
If HRV metrics derived from a wrist-worn wearable are related
to clinical measures of physical function and further explain
variability in physical health status, a wearable tool could be a
useful addition to regular clinical geriatric health assessments
for older adults. The primary aim of this study was to investigate
associations between HRV measured with a wrist-worn PPG
device, the Empatica E4 sensor (Empatica Inc) [30,31], and
widely used and validated clinical measures of physical function,
including Short Physical Performance Battery (SPPB) scores,
Timed Up and Go (TUG) scores [32-34], and self-reported
physical function (SF-36 physical composite scores) [35], in a
cohort of older adults living independently in a continuing care
senior housing community (CCSHC). We selected the SPPB,
TUG, and SF-36 as objective and subjective measures of
physical capacity and function, respectively, because they are
a few of the most widely used measures of physical function in
clinical geriatric research and health assessments [36-39]. Our
primary hypothesis was that lower HRV would be associated
with lower physical function. We further investigated whether
HRV could explain additional variability in physical health
status, as measured by the SF-36 physical composite scores and
the presence and severity of physical comorbidities via the
Cumulative Illness Severity Scale for Geriatrics (CIRS-G) [40],
beyond traditionally documented aspects of health such as age,
gender, race, blood pressure, medication and alcohol use,
smoking status, and anthropometric measurements.
Methods
Participants
The University of California San Diego (UCSD) Human
Research Protections Program (HRPP) approved the study
protocol. Research staff recruited participants from a CCSHC
in San Diego County via short presentations using an
HRPP-approved script and flyers. We recruited 77 participants
living in the independent living sector of the CCSHC, and all
of them provided written informed consent before study
participation. The inclusion and exclusion criteria for enrollment
were (1) English-speaking individuals older than 65 years, (2)
ability to complete study assessments, and (3) no known
diagnosis of dementia or other disabling illness.
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Procedures
We evaluated participants during the baseline assessment in an
ongoing study of older adults between 65 and 95 years of age
[41]. This assessment encompassed a thorough examination of
domains typically included in a geriatric health evaluation:
sociodemographic and medical health information, physical
function measurements, cognitive measurements, and additional
assessments of everyday function. The mean duration of the
assessments was 2:34:31 (HH:MM:SS; range 1:09:30-4:38:10).
The range of activities performed during this assessment
reflected the types of tasks that an individual may encounter in
their daily lives, and thus, the measure of HRV obtained from
this time period is more similar to HRV metrics obtained over
longer durations (eg, 24 hours), reflecting the cardiovascular
system’s response to a range of environmental stimuli and
workloads, as opposed to short-term measurements (eg, <5 min)
that reflect immediate responses to a particular stimulus [3].
For this investigation, we characterized participants with
sociodemographic and clinical information including age, sex,
race, education, body mass index (BMI), waist-to-hip ratio,
blood pressure, medication use (antihypertensives and
antidepressants), presence and severity of physical comorbidities
reported with the CIRS-G [40], and capacity for everyday
functioning with the UCSD Performance-Based Skills
Assessment Brief [42].
Physical Function Measurement
We assessed physical functioning with both objective,
capacity-based measures and subjective, self-reported measures.
Capacity-based measures included the SPPB and TUG test,
both of which have been shown to be valid, objective measures
of lower extremity function and mobility [32-34]. The SPPB
has 3 subcategories: the ability to stand for 10 seconds with feet
in 3 different positions (side by side, semitandem, and tandem),
2 timed trials of a 3- or 4-m walk (faster of the two), and the
time it takes to rise from a chair 5 times. Scores range from 0
to 12, with higher scores indicating better lower extremity
function. The TUG test is scored by the amount of time it takes
to rise from a chair, walk 3 m at a comfortable pace, turn, return
to the chair, and sit down. A shorter time to complete the test
indicates better mobility. For self-reported physical functioning,
we used the physical composite score from the Medical
Outcomes Study Short Form 36 (SF-36), which is a globally
used questionnaire for assessing 8 dimensions of health-related
quality of life [35]. The physical composite score is an aggregate
of the 8 scale scores reflecting self-reported physical health
[43].
Heart Rate Variability Measurement
We collected raw PPG signals and interbeat intervals for the
calculation of HRV with a wrist-worn device called the
Empatica E4 [30,31]. Research staff placed the Empatica E4
wristband on a participant’s nondominant wrist at the onset of
the assessment. During the first few minutes, the staff member
checked the quality of the PPG signal in real time through the
E4 application to ensure proper wrist placement as
recommended by Empatica. Wrist-worn PPG sensors tend to
be more accurate at rest than during exercise because of
contamination from movement artifacts and often require
accelerometry technology to measure consistent or repetitive
movements to minimize influence of these artifacts [21,44-47].
The PPG sensor in the Empatica E4 is designed to be robust
against movement artifacts in that it can attenuate noise even
when movements are not repetitive in nature, using an artifact
removal technique based on a combination of multiple infrared
light wavelengths [30].
The Empatica E4 provided continuous heart rate and interbeat
intervals that were not interpolated. It removed interbeat
intervals that corresponded to regions where the PPG signal
was not clear. For postprocessing, we downloaded the interbeat
intervals provided in a comma-separated value file format from
the E4 connect application. We viewed each interbeat interval
time series in MATLAB R2016a (MathWorks, Inc) and
calculated the percentage of gaps in the data (ie, nonconsecutive
interbeat intervals) for each participant. We removed 19
participants from data analyses because of poor-quality interbeat
interval recordings with greater than 20% gaps between interbeat
intervals that resulted in less than 20 min of recorded
high-quality interbeat interval data. We then processed the
remaining data with Kubios HRV standard software version
3.1.0 using a low threshold artifact correction to adjust for any
remaining ectopic beats and the smoothing priors detrending
method (default λ=500) [48,49].
Selecting an HRV metric requires careful consideration of the
strengths and limitations of wrist-worn PPG devices. The
Empatica E4 uses algorithms to remove errant interbeat intervals
and provides the remaining clean data that contain regions where
interbeat intervals are not necessarily consecutive [30,31,50].
To overcome this limitation and provide a robust and valid HRV
metric, we selected a metric that is less sensitive to gaps between
interbeat intervals called the HRV TI [44,51,52]. The HRV TI
is a geometric index calculated as the integral of the density
distribution of interbeat intervals divided by the maximum of
the density distribution [28] with larger numbers indicating
more favorable HRV. The HRV TI requires a longer recording
period (approximately 20 min), is robust against missing
interbeat intervals, and has good intraindividual reproducibility
[28]. For these reasons, we selected the HRV TI and analyzed
the longest recording period available for each participant (ie,
full-length assessment) for greater measurement stability.
Statistical Analyses
Given the exploratory nature of this study, we did not perform
a formal a priori power analysis. We performed correlational
statistical analyses in SPSS version 25 and generalized
estimating equation (GEE) regression with backward elimination
in R version 3.4.1. We used Spearman correlation coefficients
to assess bivariate correlations between the HRV TI measured
across the full assessment period and SPPB, TUG, and SF-36
physical composite scores. We removed an additional 5
participants from correlational analyses for the suspected
presence of arrythmia based on an HRV TI greater than 20.42
[53]. We were also missing SPPB scores for 1 participant, TUG
scores for 2 participants, and SF-36 physical composite scores
for 4 participants. We included the remaining participants in
analyses (n=52, SPPB; n=51, TUG; and n=49, SF-36 physical
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composite). We conducted Mann-Whitney U tests to determine
if there were differences between the participants removed from
analyses and those retained. For our primary analyses, we first
examined correlations between the HRV TI and variables that
have been previously shown to be related to HRV including
age, BMI, blood pressure, and mean heart rate [4,54]. We also
looked for group differences in the HRV TI between men and
women and between participants on versus off antihypertensive
and antidepressant medications [16]. We used these results to
determine whether to adjust for any of these variables using
partial correlations (ie, control for one or more of these variables
using nonparametric partial correlation syntax in SPSS if any
covariates could potentially modify our primary bivariate
relationships of interest). For the regression analyses, we
included n=42 participants with complete data on all potential
covariates (age, gender, race, blood pressure, BMI, waist-to-hip
ratio, SPPB and TUG scores, antihypertensive and
antidepressant use, alcohol use, smoking status, SF-36 physical
composite or CIRS-G scores depending on the model, and
HRV). We checked variance inflation factors (VIFs) for each
covariate and considered a covariate with VIF greater than 3 as
having high multicollinearity [55]. We rebuilt linear models
and recalculated VIFs for each covariate after excluding
covariates with a VIF greater than 3 and repeated this exclusion
process until all covariates had a VIF less than 3. To build the
regression model, we started with all variables of VIF less than
or equal to 3 in the GEE model [56]. We then iteratively
removed the variable with the largest P value, rebuilt a new
GEE model based on the remaining variables, and recalculated
P values for each variable. We repeated this process until all
remaining variables had a P value at a threshold of less than or
equal to .2. The backward elimination procedure ensured
minimum bias in the final model [57]. We derived R2 values
using the linear model. We established statistical threshold for
each family of statistical tests: correlational significance to a
Bonferroni adjusted P≤.017 (0.05/3 primary outcomes of
interest) and P≤.025 for the regressions (0.05/2 regression
analyses).
Results
We did not find significant differences for any variable in Table
1 between the individuals removed from correlational analyses
and those that we retained (P=.17 to P=.99). Heart rate remained
within a normal range during the baseline assessment: mean of
76 beats per minute (range 63-93). Mean heart rate over the
course of the assessment was inversely correlated with the mean
interbeat interval length ρ=−0.78 and P≤.001 (Figure 1) as
expected, because a higher heart rate corresponds to a shorter
duration between beats and vice versa.
There were no significant differences in the HRV TI based on
sex (U=242.5; P=.40), antihypertensive medication use
(U=271.5; P=.37), or antidepressant medication use (U=147.0;
P=.59). We also did not observe significant correlations between
any potential covariate and both HRV TI and physical function
measures (ie, variables that could potentially modify these
bivariate relationships; Table 2). Therefore, we did not adjust
for any variables using partial correlations for our primary
hypothesis regarding relationships between HRV TI and physical
function measures. HRV TI was significantly related to SPPB,
TUG, and SF-36 physical composite scores (Table 2 and Figure
2). We also observed an inverse relationship between HRV TI
and CIRS-G scores (Figure 2).
Results of the regression revealed that the HRV TI explained a
significant proportion of variance in physical health status as
characterized by both SF-36 physical composite and CIRS-G
scores. R2 values increased from 0.11 to 0.28, with the HRV TI
included in estimating SF-36 physical composite scores, and
from 0.17 to 0.33, with the HRV TI included in estimating
CIRS-G scores. Additional significant correlates for these
measures of physical health status following the backward
elimination procedure included gender, BMI, medication use,
and smoking status (Table 3). VIF values were all less than 2.0,
suggesting minimal collinearity.
JMIR Mhealth Uhealth 2019 | vol. 7 | iss. 10 | e13757 | p. 4http://mhealth.jmir.org/2019/10/e13757/
(page number not for citation purposes)
Graham et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
Table 1. Sociodemographic information and other variables collected from participants.
ValuesVariable name
82.9 (6.7); 67-98Age (years; n=77), mean (SD); range
52 (68)Gender (n=77); number of females, n (%)
15.8 (2.4); 12-20Education (years; n=77), mean (SD); range
68 (88)Race (n=77); number of whites, n (%)
27.9 (4.9); 19-43Body mass index (kg/m2; n=76), mean (SD); range
0.87 (0.08); 0.71-1.06Waist-to-hip ratio (ratio; n=75), mean (SD); range
134 (17); 100-167Systolic blood pressure (mm Hg; n=74), mean (SD); range
75 (9); 56-94Diastolic blood pressure (mm Hg; n=74), mean (SD); range
76.1 (12.5); 37.4-100.0University of California San Diego Performance-Based Skills Assessment Brief (score; n=77), mean (SD); range
8.8 (3.2); 2-15Cumulative Illness Rating Scale for Geriatrics (score; n=76), mean (SD); range
48 (62)Antihypertensives (n=75); number of participants using, n (%)
13 (17)Antidepressants (n=75); number of participants using, n (%)
1 (1)Current smoker (n=75); number of participants smoking, n (%)
Alcohol use (n=68), n (%)
6 (9)Lifetime abstainer (number of yes; [% abstaining])
36 (53)Current infrequent drinker (number of yes; [% drinking])
17 (25)Current regular drinker (number of yes; [% drinking])
9 (13)Former drinker (number of yes; [% used to drink])
8.2 (2.7); 0-12Short Physical Performance Battery (score out of 12; n=76), mean (SD); range
11.0 (3.1); 6.1-23.0Timed up and Go time (seconds; n=74), mean (SD; range)
41.8 (10.7); 18.3-60.1Short Form 36 physical composite (score out of 100; n=70), mean (SD); range
11.4 (2.9); 3.7-17.2Heart rate variability triangular index (n=53), mean (SD); range
Figure 1. Scatterplot of the relationship between mean heart rate across the entire evaluation and mean interbeat interval length: n=52; Spearman
correlation=−0.78; P≤.001. bpm: beats per minute.
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Table 2. Bivariate correlations among all variables. Correlations for primary hypotheses are in italics.
ρ (P value)Variables
Mean HRh
(n=53)
Dia BPg
(n=50)
Sys BPf
(n=50)
Waist to hip
ratio (n=52)
BMIe
(n=51)
Age
(n=53)
CIRS-Gd
(n=52)
SF-36 phys
compc (n=49)
TUGb
(n=51)
SPPBa
(n=52)
−0.36j;
(.009)
0.01;
(.97)
0.07;
(.63)
−0.20;
(.16)
0.07;
(.64)
−0.10;
(.47)
−0.43j;
(.001)
0.37j;
(.009)
−0.40j;
(.004)
0.41j;
(.003)
HRV TIi (n=53)
−0.04;
(.80)
0.10;
(.49)
0.06;
(.69)
−0.08;
(.58)
0.10;
(.48)
−0.29;
(.04)
−0.23;
(.11)
0.59l;
(≤.001)
−0.79l;
(≤.001)
—
kSPPB
0.18;
(.20)
−0.13;
(.39)
−0.02;
(.87)
0.10;
(.50)
−0.15;
(.30)
0.40j;
(.004)
0.19;
(.18)
−0.39j;
(.007)
——TUG
−0.07;
(.65)
−0.10;
(.95)
−0.08;
(.61)
−0.08;
(.59)
0.07;
(.65)
−0.24;
(.10)
−0.65l;
(≤.001)
———SF-36 phys comp
0.09;
(.54)
−0.03;
(.84)
−0.02;
(.88)
−0.05;
(.75)
0.19;
(.19)
−0.20;
(.16)
————CIRS-G
0.00;
(>.99)
0.18;
(.21)
0.35j;
(.01)
0.40l;
(.003)
−0.14;
(.34)
—————Age
−0.21;
(.14)
0.13;
(.37)
−0.12;
(.42)
0.01;
(.95)
——————BMI
−0.09;
(.51)
0.05;
(.74)
0.13;
(.36)
———————Waist to hip ratio
−0.11;
(.46)
0.64l;
(≤.001)
————————Sys BP
−0.03;
(.85)
—————————Dia BP
aSPPB: Short Physical Performance Battery.
bTUG: Timed Up and Go.
cSF-36 phys comp: Short Form 36 physical composite score.
dCIRS-G: Cumulative Illness Rating Scale for Geriatrics.
eBMI: body mass index.
fSys BP: systolic blood pressure.
gDia BP: diastolic blood pressure.
hHR: heart rate.
iHRV TI: heart rate variability triangular index.
jP≤.017.
kNot applicable.
lP≤.001.
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Figure 2. Scatter plots of the relationships between heart rate variability triangular index (TI) and (a) Short Physical Performance Battery scores (n=52),
(b) Timed Up and Go scores (n=51), (c) Short Form 36 physical composite scores (n=49), and (d) Cumulative Illness Rating Scale for Geriatrics
(CIRS-G) scores (n=52). HRV: heart rate variability; SF-36: Short Form 36.
Table 3. Results of the regression analyses (backward selection): remaining significant correlates of physical health status characterized by Short Form
36 physical composite scores and Cumulative Illness Rating Scale for Geriatrics scores. Adjusted R2 of the full model for SF-36 scores=0.28 and for
CIRS-G scores=0.33.
P valueRobust zRobust SENaïve zNaïve SEEstimateParameter
SF-36a physical composite score
≤.0013.646.053.795.8122.01Intercept
≤.0013.580.443.380.471.58HRV TIb
.042.112.791.963.015.88Gender
.02−2.352.53−2.202.71−5.95Antihypertensives
.0062.732.462.482.716.72Smoking status
CIRS-Gc score
.0023.072.802.853.028.62Intercept
≤.001−4.560.10−3.410.14−0.46HRV TId
.05−1.930.81−1.750.89−1.56Gender
.051.960.071.700.090.15BMIe
≤.0013.570.713.050.832.52Antihypertensives
.161.410.951.470.911.34Antidepressants
aSF-36: short form 36.
bHRV TI: heart rate variability triangular index
cCIRS-G: Cumulative Illness Rating Scale for Geriatrics.
dHRV: heart rate variability.
eBMI: body mass index.
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Discussion
Principal Findings
In this study, we explored relationships between HRV measured
using a wrist-worn device and both capacity-based and
self-reported measures of physical function obtained during a
standard clinical geriatric assessment of older adults living
independently in a CCSHC. Our primary hypothesis was
supported as we observed significant relationships between the
HRV TI and both capacity-based measures of physical
function—that is, the SPPB and TUG [32-34] and self-reported
physical function, as measured by the SF-36 physical composite
score [35,43]. In addition, we observed that the HRV TI
explained a significant proportion of variance in physical health
status, as characterized by SF-36 physical composite and
CIRS-G scores [40].
Relationships Between Heart Rate Variability, Physical
Function, and Physical Health
The relationships between the HRV TI and both the SPPB and
TUG and self-reported measures of physical function are
noteworthy. Self-reported and capacity-based measures of
physical capacity are reported to contribute information about
physical function in different ways [58]. For example,
self-reported measures are more effective in distinguishing
among persons at lower levels of physical function who may
not be able to complete capacity-based tests [59]. In contrast,
self-reported measures fail to differentiate well among persons
in the mid- or high range of functioning. Capacity-based
measures provide information across a broader range of physical
function and discriminate more effectively than self-reported
measures at higher capacities [59]. We observed significant
relationships between SPPB and TUG scores and self-reported
physical function in our sample. We also observed an inverse
relationship between the presence of physical comorbidities
and self-reported physical function, which is consistent with
previous reports demonstrating that older adults who report
more health problems also report lower levels of perceived
function [60]. Presence of physical comorbidities (CIRS-G)
was related to the HRV TI but not to either SPPB or TUG scores
in this study. Therefore, HRV TI may characterize a
complementary aspect of older adults’ physical health that is
not captured by physical capacity measures.
Previous work has identified relationships between HRV
quantified via standard ECG or Holter monitoring and aspects
of older adults’ physical function [5,16,19]. In particular, frailty
appears to be linked to a loss of physiologic flexibility, as
quantified by nonlinear HRV dynamics [16,17]. If changes in
HRV precede physical decline, then regular measurement of
HRV may be a useful biomarker for older adults. Low HRV,
along with male sex, older age, and smoking, has also been
reported to be a significant predictor of chronic diseases
including hypertension and hyperglycemia and a diagnosis of
diabetes within 12 years [61]. These findings suggest that
monitoring of HRV may help to identify individuals at high
risk for both physical decline and development of chronic
diseases.
High HRV has been described as a measure of adaptability [62],
which is directly related to maintenance of physical function.
The consistent relationships observed between the HRV TI and
measures of physical function and physical health in this study
suggest that HRV TI quantified with a wearable device is indeed
related to physical function and cumulative illness burden in
older adults. These relationships were not accounted for by a
direct association between HRV and age, suggesting that this
measure of autonomic function may be useful for aging research.
This finding is not surprising given that previous relationships
between HRV and age have generally been observed across a
much broader age span [4,14,15,28]. Although standard ECG
and Holter monitor recordings have been useful for risk
stratification in a variety of pathologic conditions [62-64], our
findings suggest that a wearable device may also be useful for
quantifying autonomic dysfunction in older adults. Although
HRV was significantly associated with physical capacity
measures, mean heart rate was not, suggesting that measurement
of heart rate alone does not capture the relationship between
autonomic regulation and physical function.
Wearable Technology for Heart Rate Variability
Measurement
The accessibility of wearable technology [29] and the
relationships between HRV derived from a wrist-worn wearable
and measures of physical function suggest that incorporating
wearables for HRV monitoring into clinical geriatric assessments
could potentially help in the early detection of physical decline.
In particular, watch-like devices are ideal because they are
noninvasive and small and do not interfere with the activities
performed during clinical geriatric health assessments. These
devices are also relatively low cost, do not require expert setup,
and may be more easily deployed than ECG equipment in
remote home-health settings. In the future, such wearables may
be ideal for monitoring the health of older adults, further
enabling early detection of physical decline and early
intervention to improve autonomic regulation and possibly delay
deterioration of physical function. However, such long-term
monitoring of HRV via wearable devices will necessitate careful
consideration of the adoption of technology by older adults and
ethical concerns such as data privacy and informed consent
[65]. It may also be important to monitor HRV in younger
populations, given the observed relationships to measures of
physical health status in this study and the fact that declining
physical function does not happen only in adults older than 65
years. HRV is known to decline with age, particularly before
the age of 60 years, but these correlations are only modest [14].
Thus, perhaps those with poorer physical health also exhibit
greater tendency for decline. If HRV metrics are related to the
physical health status of younger adults as well, early
identification of declining HRV may enable more timely
intervention to mitigate further decline.
Future Goals for Heart Rate Variability Measurement
In this study, we measured HRV during a single assessment to
demonstrate relationships between HRV metrics quantified with
a wearable device and clinical measures of physical function;
however, we intend to track this cohort of participants
longitudinally. These findings will help determine whether HRV
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from a wearable device predicts or coincides with changes in
physical function. We are also interested in the feasibility of
more frequent HRV measurements using wrist-worn devices
for older adults and plan to examine day-to-day variability of
HRV metrics. The clinical value of HRV measurement is likely
to be at the level of the individual and not the group; thus,
identifying changes outside of an individual’s normal HRV
range may lend the most insight into incipient decline.
Study Limitations
This study had several limitations. This was a small sample of
predominantly white and middle-to-upper class older adults, so
our findings may not apply to other populations. We also had
a majority of female participants, which may have prevented
us from detecting differences in HRV due to gender. However,
gender differences in HRV have been reported to disappear
after the age of 50 years [14]. Furthermore, the cross-sectional
nature of this investigation precludes the ability to draw causal
relationships between the variables investigated. We investigated
only 1 PPG device, the Empatica E4 sensor, in this study.
However, we did not use an HRV metric provided by this device
(Empatica does not offer these data). We simply used the device
to collect raw interbeat interval data and then used the
well-known Kubios HRV software [48] to calculate HRV TI.
The presence of missing interbeat intervals influenced our choice
of HRV metric (we selected the HRV TI instead of others) and,
in particular, prevented us from using frequency-based HRV
metrics as they are affected by missing interbeat intervals. As
frequency-based metrics are reported to be more descriptive of
the balance between sympathetic and parasympathetic activity
[66], improving the quality of interbeat interval recordings from
wearable devices is of considerable importance. We also had
to remove a considerable number of participants from statistical
analyses because of poor-quality interbeat interval recordings.
Future research directed at refining wearable technology such
as the Empatica E4 to improve the quality of recordings (eg,
further minimize movement artifacts) will be essential in
improving the utility of these devices. Finally, we cannot easily
compare the HRV TI values obtained in this study to previously
established norms for several reasons, including less frequent
reporting of the HRV TI metric, differences in calculation
methods, and differing durations of recordings (eg, often done
over a 24-hour period).
Conclusions
In summary, we demonstrated that the HRV TI measured using
a relatively novel wearable device, the Empatica E4 sensor, was
related to both objective (SPPB and TUG) and self-reported
(SF-36 physical composite) measures of physical function of
older adults and cumulative illness burden (CIRS-G) collected
during a single assessment. In addition, the HRV TI explained
a significant proportion of variance in physical health status, as
characterized by the SF-36 physical composite scores and
CIRS-G scores, beyond typically measured aspects of physical
health. The next steps include longitudinal tracking of changes
in both HRV and physical function, which will add important
insights regarding the possible predictive value of HRV as a
biomarker of functional outcomes in older adults.
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